MDWD
MediWound·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MDWD fundamentals
MediWound (MDWD) released its earnings on Nov 20, 2025: revenue was 5.43M (YoY +24.83%), missed estimates; EPS was -0.24 (YoY +75.51%), beat estimates.
Revenue / YoY
5.43M
+24.83%
EPS / YoY
-0.24
+75.51%
Report date
Nov 20, 2025
MDWD Earnings Call Summary for Q3,2025
- EscharEx Peak Sales Estimate: Updated to $831M, driven by HEOR benefits and 50% premium pricing strategy.
- NexoBrid Growth: 38% YoY revenue growth, 6x manufacturing capacity expansion on track for 2025. BARDA contract resumption expected post-shutdown.
- Financial Resilience: $60M cash position supports strategic initiatives, 9M gross margin 19.7%.
EPS
Revenue
Revenue & Expenses
MDWD has released its 2025 Q3 earnings report, with revenue of 5.43M, reflecting a YoY change of 24.66%, and net profit of -2.65M, showing a YoY change of 74.21%. The Sankey diagram below clearly presents MDWD's revenue sources and cost distribution.
Key Indicators
MediWound (MDWD) key financial stats and ratios, covering profitability, financial health, and leverage.
MediWound (MDWD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
MediWound (MDWD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
MediWound (MDWD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does MediWound (MDWD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track MediWound (MDWD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
